The Protective Effect of Imatinib Against Pancreatic β-cell Apoptosis Induced by Dexamethasone Via Increased GSTP1 Expression and Reduced Oxidative Stress

Overview

Journal Sci Rep

Specialty Science

Date 2024 Jul 31

PMID 39085384

Authors

Namoiy Semprasert

Petcharee Maneethorn

Suwattanee Kooptiwut

Affiliations

Soon will be listed here.

Abstract

Glucocorticoids (GCs) are known to stimulate pancreatic beta (β)-cell apoptosis via several mechanisms, including oxidative stress. Our previous study suggested an increase in dexamethasone-induced pancreatic β-cell apoptosis via a reduction of glutathione S-transferase P1 (GSTP1), which is an antioxidant enzyme. Imatinib, which is a tyrosine kinase inhibitor, also exerts antioxidant effect. This study aims to test our hypothesis that imatinib would prevent pancreatic β-cell apoptosis induced by dexamethasone via increased GSTP1 expression and reduced oxidative stress. Our results revealed that dexamethasone significantly increased apoptosis in INS-1 cells when compared to the control, and that imatinib significantly decreased INS-1 cell apoptosis induced by dexamethasone. Moreover, dexamethasone significantly increased superoxide production in INS-1 cells when compared to the control; however, imatinib, when combined with dexamethasone, significantly reduced superoxide production in INS-1 cells. Dexamethasone significantly decreased GSTP1, p-ERK1/2, and BCL2 protein expression, but significantly increased p-JNK, p-p38, and BAX protein expression in INS-1 cells-all compared to control. Importantly, imatinib significantly ameliorated the effect of dexamethasone on the expression of GSTP1, p-ERK1/2, p-JNK, p-p38 MAPK, BAX, and BCL2. Furthermore-6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio) hexanol (NBDHEX), which is a GSTP1 inhibitor, neutralized the protective effect of imatinib against pancreatic β-cell apoptosis induced by dexamethasone. In conclusion, imatinib decreases pancreatic β-cell apoptosis induced by dexamethasone via increased GSTP1 expression and reduced oxidative stress.

References

Elksnis A, Schiffer T, Palm F, Wang Y, Cen J, Turpaev K . Imatinib protects against human beta-cell death via inhibition of mitochondrial respiration and activation of AMPK. Clin Sci (Lond). 2021; 135(19):2243-2263. DOI: 10.1042/CS20210604. View

Idris H, Elderdery A, Khalil H, Mills J . Genetic Polymorphism of GSTP1, GSTM1 and GSTT1 Genes and Susceptibility to Chronic Myeloid Leukaemia. Asian Pac J Cancer Prev. 2020; 21(2):499-503. PMC: 7332153. DOI: 10.31557/APJCP.2020.21.2.499. View

Zawalich W, Tesz G, Yamazaki H, Zawalich K, Philbrick W . Dexamethasone suppresses phospholipase C activation and insulin secretion from isolated rat islets. Metabolism. 2005; 55(1):35-42. DOI: 10.1016/j.metabol.2005.06.023. View

Klusek J, Blonska-Sikora E, Witczak B, Orlewska K, Klusek J, Gluszek S . Glutathione S-transferases gene polymorphism influence on the age of diabetes type 2 onset. BMJ Open Diabetes Res Care. 2020; 8(2). PMC: 7674104. DOI: 10.1136/bmjdrc-2020-001773. View

Mian O, Khattab M, Hedayati M, Coulter J, Abubaker-Sharif B, Schwaninger J . GSTP1 Loss results in accumulation of oxidative DNA base damage and promotes prostate cancer cell survival following exposure to protracted oxidative stress. Prostate. 2015; 76(2):199-206. PMC: 4734373. DOI: 10.1002/pros.23111. View

Liu L, Zhou J, Wang Y, Qi T, Wang Z, Chen L . Imatinib inhibits oxidative stress response in spinal cord injury rats by activating Nrf2/HO-1 signaling pathway. Exp Ther Med. 2020; 19(1):597-602. PMC: 6923749. DOI: 10.3892/etm.2019.8270. View

Hagerkvist R, Makeeva N, Elliman S, Welsh N . Imatinib mesylate (Gleevec) protects against streptozotocin-induced diabetes and islet cell death in vitro. Cell Biol Int. 2006; 30(12):1013-7. DOI: 10.1016/j.cellbi.2006.08.006. View

Donihi A, Raval D, Saul M, Korytkowski M, DeVita M . Prevalence and predictors of corticosteroid-related hyperglycemia in hospitalized patients. Endocr Pract. 2006; 12(4):358-62. DOI: 10.4158/EP.12.4.358. View

Chan J, Malik V, Jia W, Kadowaki T, Yajnik C, Yoon K . Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA. 2009; 301(20):2129-40. DOI: 10.1001/jama.2009.726. View

10.

Xia C, Zhang P, Li S, Yuan L, Xia T, Xie C . C-Abl inhibitor imatinib enhances insulin production by β cells: c-Abl negatively regulates insulin production via interfering with the expression of NKx2.2 and GLUT-2. PLoS One. 2014; 9(5):e97694. PMC: 4023982. DOI: 10.1371/journal.pone.0097694. View

11.

Ranta F, Avram D, Berchtold S, Dufer M, Drews G, Lang F . Dexamethasone induces cell death in insulin-secreting cells, an effect reversed by exendin-4. Diabetes. 2006; 55(5):1380-90. DOI: 10.2337/db05-1220. View

12.

MohanKumar S, Murugan A, Palaniyappan A, MohanKumar P . Role of cytokines and reactive oxygen species in brain aging. Mech Ageing Dev. 2023; 214:111855. PMC: 10528856. DOI: 10.1016/j.mad.2023.111855. View

13.

Di Dalmazi G, Pagotto U, Pasquali R, Vicennati V . Glucocorticoids and type 2 diabetes: from physiology to pathology. J Nutr Metab. 2013; 2012:525093. PMC: 3536319. DOI: 10.1155/2012/525093. View

14.

Lee N, Park S, Yee J, Yoon H, Han J, Gwak H . Association Between Glutathione-S-Transferase Gene Polymorphisms and Responses to Tyrosine Kinase Inhibitor Treatment in Patients with Chronic Myeloid Leukemia: A Meta-analysis. Target Oncol. 2020; 15(1):47-54. DOI: 10.1007/s11523-020-00696-z. View

15.

Strange R, Spiteri M, Ramachandran S, Fryer A . Glutathione-S-transferase family of enzymes. Mutat Res. 2001; 482(1-2):21-6. DOI: 10.1016/s0027-5107(01)00206-8. View

16.

Landry W, Woolley J, Cotter T . Imatinib and Nilotinib inhibit Bcr-Abl-induced ROS through targeted degradation of the NADPH oxidase subunit p22phox. Leuk Res. 2012; 37(2):183-9. DOI: 10.1016/j.leukres.2012.11.003. View

17.

Hoogwerf B, Danese R . Drug selection and the management of corticosteroid-related diabetes mellitus. Rheum Dis Clin North Am. 1999; 25(3):489-505. DOI: 10.1016/s0889-857x(05)70083-1. View

18.

Adel M, Elsayed H, El-Nablaway M, Hamed S, Eladl A, Fouad S . Targeting Hydrogen Sulfide Modulates Dexamethasone-Induced Muscle Atrophy and Microvascular Rarefaction, through Inhibition of NOX4 and Induction of MGF, M2 Macrophages and Endothelial Progenitors. Cells. 2022; 11(16). PMC: 9406793. DOI: 10.3390/cells11162500. View

19.

Chen Y, Tseng H, Kuo W, Yang S, Chen D, Tsai H . Glutathione S-Transferase P1 (GSTP1) gene polymorphism increases age-related susceptibility to hepatocellular carcinoma. BMC Med Genet. 2010; 11:46. PMC: 2851593. DOI: 10.1186/1471-2350-11-46. View

20.

Stephens R, Johnston L, Servinsky L, Kim B, Damarla M . The tyrosine kinase inhibitor imatinib prevents lung injury and death after intravenous LPS in mice. Physiol Rep. 2015; 3(11). PMC: 4673626. DOI: 10.14814/phy2.12589. View